unknown
Stage
About
HistaPharma Sp. z o.o. is a Poland-based pharmaceutical company developing medicinal products for respiratory and allergic diseases, including asthma, COPD, allergic rhinitis, skin allergies and chronic urticaria. The company is working on drug development and regulatory activities (including a generic rupatadine product) and is a public–private venture backed by Bridge Alfa / YouNick Mint and the National Centre for Research and Development.
Explore HistaPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.